The GLP-1 agonists semaglutide and liraglutide, which seem new and therefore more risky, have been used for almost 20 years for people with type 2 diabetes and have been shown to be safe and well-tolerated, Levy says
Our Treatments How It Works Patient Resources For Providers Our Treatments How It Works Patient Resources For Providers Find A Provider Sign In DrWell Home Our Treatments How It Works Patient Resources For Providers Find a Provider Sign In DrWell Home Our Treatments How It Works Patient Resources For Providers Find a Provider Sign In Providers , Webinars Webinar recording: Get ready for a GLP-1 BOOM in the age of TrumpRx
Read More The rise of obesity Development, investments, partnerships climb, but safety is key The ability of obesity medications to impact co-morbidities, reducing the symptoms and costs associated with down-the-road disease, has attracted significant attention throughout the biopharma industry
Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep
